114 related articles for article (PubMed ID: 4545357)
21. [Lymphocyte culture in the presence of phytohemagglutinins in Hodgkin's disease].
Ferrari S; Foggi CM; Serafini NA
Ann Ist Carlo Forlanini; 1968; 28(3):292-309. PubMed ID: 4903142
[No Abstract] [Full Text] [Related]
22. Proceedings: T and B blocking factors in Hodgkin's disease.
Bentwich Z; Cohen R; Brautbar C
Isr J Med Sci; 1975 Dec; 11(12):1382. PubMed ID: 1082876
[No Abstract] [Full Text] [Related]
23. International symposium on Hodgkin's disease. Session I. Epidemiology and etiology. Part 3. Immunology. Introduction.
Good RA
Natl Cancer Inst Monogr; 1973 May; 36():93-4. PubMed ID: 4582999
[No Abstract] [Full Text] [Related]
24. Responses to tests of cell mediated immunity before, during and after BCG administration in Hodgkin's disease.
Lenzini L; Bracci R; Rottoli P; Rottoli L
Boll Ist Sieroter Milan; 1974; 53(1):suppl:300. PubMed ID: 4546904
[No Abstract] [Full Text] [Related]
25. [The target cell for antilymphocyte antibodies in Hodgkin's disease].
Del Giacco GS; Manconi PE; Tognella S; Mantovani G; Turno R; Grifoni V
Boll Ist Sieroter Milan; 1974; 53(4):562-4. PubMed ID: 4615725
[No Abstract] [Full Text] [Related]
26. Subpopulations of human T lymphocytes in patients with Hodgkin's disease before and after treatment.
Karande AA; Gulwani B; Advani SH; Gangal SG
Neoplasma; 1982; 29(2):149-59. PubMed ID: 6981068
[TBL] [Abstract][Full Text] [Related]
27. Stage-dependent reduction in T colony formation in Hodgkin's disease. Coincidence with monocyte synthesis of prostaglandins.
Bockman RS
J Clin Invest; 1980 Sep; 66(3):523-31. PubMed ID: 6967491
[TBL] [Abstract][Full Text] [Related]
28. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
Schmidt U; Herbst J; Metz KA; Leder LD
J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
[TBL] [Abstract][Full Text] [Related]
29. Immunological aspects of Hodgkin's disease.
Baldwin RW
Proc R Soc Med; 1972 Dec; 65(12):1113. PubMed ID: 4346774
[No Abstract] [Full Text] [Related]
30. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
Zółtowska A; Arendt M; Gan J
Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594
[TBL] [Abstract][Full Text] [Related]
31. Thymus-derived lymphocyte (T-cell) depletion in Hodgkin's disease.
Ramot B; Many A; Biniaminov M; Aghai E
Isr J Med Sci; 1973 May; 9(5):657-9. PubMed ID: 4577862
[No Abstract] [Full Text] [Related]
32. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
[TBL] [Abstract][Full Text] [Related]
33. The immune derangement in Hodgkin's disease.
Romagnani S; Ferrini PL; Ricci M
Semin Hematol; 1985 Jan; 22(1):41-55. PubMed ID: 3155877
[No Abstract] [Full Text] [Related]
34. Distinguishing features of the immunology of Hodgkin's disease in children.
Tan CT; De Sousa M; Good RA
Cancer Treat Rep; 1982 Apr; 66(4):969-75. PubMed ID: 7074657
[TBL] [Abstract][Full Text] [Related]
35. Nature of the T lymphocytes in lymphocyte predominance Hodgkin's disease.
Dargent JL; Schandene L; Kornreich A; Lespagnard L; Cochaux P; Jagodzinski R; Capel P; Velu T; Neve P
Leuk Lymphoma; 1997 Feb; 24(5-6):545-51. PubMed ID: 9086445
[TBL] [Abstract][Full Text] [Related]
36. [The rosette test with sensitized sheep erythrocytes, acid phosphatase and alpha-naphthylacetate esterase in an acid medium: comparative immunocytochemical T-cell exhibition in Hodgkin's disease].
Plat M; Plat U; Fleischer J; Wolf H; Palitzsch M; Hofmann R; Reinhardt U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(1):87-95. PubMed ID: 2472333
[No Abstract] [Full Text] [Related]
37. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
[TBL] [Abstract][Full Text] [Related]
38. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
Churchill WH; Rocklin RR; Moloney WC; David JR
Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
[No Abstract] [Full Text] [Related]
39. The effect of peripheral blood lymphocyte stimulation on zeta chain expression and IL-2 production in Hodgkin's disease.
Frydecka I; Boćko D; Kosmaczewska A; Ciszak L; Morilla R
Br J Cancer; 2001 May; 84(10):1339-43. PubMed ID: 11355944
[TBL] [Abstract][Full Text] [Related]
40. Lymphocytic characterization in Hodgkin's and non-Hodgkin's lymphoma.
Kamthan M; Joshi N; Sharma ML
Indian J Pathol Microbiol; 1982 Apr; 25(2):139-43. PubMed ID: 6982850
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
